Madurella mycetomatis, the main causative agent of eumycetoma, is highly susceptible to olorofim

OBJECTIVES: Eumycetoma is currently treated with a combination of itraconazole therapy and surgery, with limited success. Recently, olorofim, the lead candidate of the orotomides, a novel class of antifungal agents, entered a Phase II trial for the treatment of invasive fungal infections. Here we de...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Antimicrob Chemother
Главные авторы: Lim, Wilson, Eadie, Kimberly, Konings, Mickey, Rijnders, Bart, Fahal, Ahmed H, Oliver, Jason D, Birch, Mike, Verbon, Annelies, van de Sande, Wendy
Формат: Artigo
Язык:Inglês
Опубликовано: Oxford University Press 2020
Предметы:
Original Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7069493/
https://ncbi.nlm.nih.gov/pubmed/31904836
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkz529
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы